Common use of Recombinant DNA Clause in Contracts

Recombinant DNA. SCOR Director and Sponsoring Institution acknowledge that the statement in the Application concerning recombinant DNA and the safeguards to be employed is an accurate description of the circumstances pertaining to this aspect of the research proposed in the Application. Projects which do not involve recombinant DNA must so state. Failure to notify LLS of non- compliance with these guidelines on the use of recombinant DNA will result in suspension or termination of this Agreement.

Appears in 2 contracts

Sources: Specialized Center of Research Grant Agreement, Specialized Center of Research Grant Agreement